Trial intelligence / Profile preview

HSK16149 Capsules for Perioperative Analgesia in Orthopedics

CTR20230594Phase 2Completed

Sponsor
Sichuan Haisco Pharmaceutical Co., Ltd.
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in perioperative pain comparing HSK16149 with Placebo (2 arms). Primary endpoint: Total morphine consumption within 24h post-operation. Started Mar 2023; status: completed.

02

Drugs

crisugabalin besilate
03

Conditions

perioperative pain

Beyond the preview

Go deeper on CTR20230594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20230594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call